Toll-like receptor 4–TRIF-dependent signaling pathway (TLR4–TRIF pathway)

The TLR4–TRIF-dependent signaling pathway is an intracellular cascade initiated by activation of Toll-like receptor 4 (TLR4), a pattern recognition receptor that detects lipopolysaccharide (LPS) from bacteria. Upon activation and internalization of TLR4, the adaptor proteins TRAM and TRIF are recruited, leading to activation of TBK1 and IKKε, phosphorylation of IRF3, and subsequent expression of type I interferons such as IFN-β, chemokines, and interferon-regulated genes[1][4][5][7]. This pathway is critical for innate immune responses, promoting dendritic cell and macrophage activation, type I IFN production, and maturation of antigen-presenting cells. It also modulates cell death pathways, including necroptosis, and plays roles in infection control, inflammation, and cancer immunotherapy. The pathway may be directly or indirectly modulated by drugs that target TLR4 or its downstream effectors, with relevance to infectious disease, autoimmunity, and vaccine adjuvant development.

Other names

TLR4–TRIF pathwayTLR4–TRIF axisTLR4 MyD88-independent pathwayTLR4–TRIF/IRF3 pathway

Agonists: activate TLR4, trigger endocytosis and recruitment of TRAM/TRIF, leading to IRF3 phosphorylation, type I IFN production, and immune cell activation Antagonists: inhibit TLR4 activation and downstream TRIF signaling (block IRF3, IFN-β induction, and inflammatory cytokine production)